Avalon BioVentures SPV I, L.P.
Insider CIK 1844550 · JANX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 102,732 | $50.30 | $5.17M | 2,629,085 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 19,900 | $50.30 | $1.00M | 509,273 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 104,892 | $50.30 | $5.28M | 2,684,380 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 15,462 | $51.18 | $791.3K | 2,613,623 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 2,995 | $51.18 | $153.3K | 506,278 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 15,788 | $51.18 | $808.0K | 2,668,592 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 104,957 | $44.75 | $4.70M | 401,321 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 553,219 | $44.75 | $24.76M | 2,115,373 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-18 | 541,824 | $44.75 | $24.25M | 2,071,799 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 348 | — | $0 | 9,142 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 348 | — | $0 | 9,142 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 836 | — | $0 | 21,940 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-17 | 2024-10-18 | 237 | — | $0 | 6,072 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-17 | 2024-10-18 | 1,843 | $50.02 | $92.2K | 6,371 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 237 | $39.80 | $9.4K | 8,214 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 836 | $17.00 | $14.2K | 7,281 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 348 | $10.73 | $3.7K | 7,629 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-17 | 2024-10-18 | 348 | $13.22 | $4.6K | 7,977 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 1,407 | — | $0 | 6,309 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 4,968 | — | $0 | 22,776 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 2,070 | — | $0 | 9,490 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-10-16 | 2024-10-18 | 2,070 | — | $0 | 9,490 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 60,179 | $49.69 | $2.99M | 2,761,291 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 11,657 | $49.69 | $579.2K | 534,883 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 61,445 | $49.69 | $3.05M | 2,819,366 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 29,474 | $50.61 | $1.49M | 2,731,817 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 5,710 | $50.61 | $289.0K | 529,173 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 30,094 | $50.61 | $1.52M | 2,789,272 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 4,968 | $17.00 | $84.5K | 11,855 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 2,070 | $10.73 | $22.2K | 13,925 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 2,070 | $13.22 | $27.4K | 15,995 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-10-16 | 2024-10-18 | 1,407 | $39.80 | $56.0K | 17,402 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-10-16 | 2024-10-18 | 10,957 | $50.80 | $556.6K | 6,445 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 434 | — | $0 | 27,744 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 181 | — | $0 | 11,560 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 181 | — | $0 | 11,560 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-09-30 | 123 | — | $0 | 7,716 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 434 | $17.00 | $7.4K | 7,360 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 181 | $10.73 | $1.9K | 7,541 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 181 | $13.22 | $2.4K | 7,722 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-09-30 | 123 | $39.80 | $4.9K | 7,845 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-30 | 2024-09-30 | 958 | $46.24 | $44.3K | 6,887 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 828 | — | $0 | 28,178 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 345 | — | $0 | 11,741 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 234 | — | $0 | 7,839 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-30 | 345 | — | $0 | 11,741 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 1,826 | $46.19 | $84.3K | 6,926 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 234 | $39.80 | $9.3K | 8,752 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 345 | $13.22 | $4.6K | 8,518 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 345 | $10.73 | $3.7K | 8,173 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-30 | 828 | $17.00 | $14.1K | 7,828 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 1,542 | $47.74 | $73.6K | 2,880,811 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 293 | $47.74 | $14.0K | 546,540 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 1,511 | $47.74 | $72.1K | 2,821,470 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 46,861 | $46.42 | $2.18M | 2,882,353 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 45,894 | $46.42 | $2.13M | 2,822,981 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-30 | 8,894 | $46.42 | $412.9K | 546,833 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 41,661 | $47.77 | $1.99M | 2,929,214 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 7,908 | $47.77 | $377.8K | 555,727 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 40,803 | $47.77 | $1.95M | 2,868,875 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 50,539 | $46.78 | $2.36M | 2,970,875 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 9,592 | $46.78 | $448.7K | 563,635 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-26 | 2024-09-30 | 49,497 | $46.78 | $2.32M | 2,909,678 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 158,031 | $47.00 | $7.43M | 2,959,175 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 161,356 | $47.00 | $7.58M | 3,021,414 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 30,613 | $47.00 | $1.44M | 573,227 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 35,047 | $46.66 | $1.64M | 3,182,770 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 6,649 | $46.66 | $310.2K | 603,840 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 34,326 | $46.66 | $1.60M | 3,117,206 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 11,557 | $46.13 | $533.1K | 3,217,817 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 2,193 | $46.13 | $101.2K | 610,489 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-12 | 11,319 | $46.13 | $522.1K | 3,151,532 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 414 | — | $0 | 12,086 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 414 | — | $0 | 12,086 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 994 | — | $0 | 29,006 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-09 | 2024-09-10 | 277 | — | $0 | 8,073 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 994 | $17.00 | $16.9K | 8,077 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 414 | $10.73 | $4.4K | 8,491 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 277 | $39.80 | $11.0K | 9,182 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-10 | 2,182 | $42.33 | $92.4K | 7,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-09 | 2024-09-10 | 414 | $13.22 | $5.5K | 8,905 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-10 | 110,644 | $42.00 | $4.65M | 3,229,374 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-10 | 20,991 | $42.00 | $881.6K | 612,682 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-06 | 2024-09-10 | 108,365 | $42.00 | $4.55M | 3,162,851 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 677,279 | $54.75 | $37.08M | 3,271,216 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 691,525 | $54.75 | $37.86M | 3,340,018 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 131,196 | $54.75 | $7.18M | 633,673 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 447,949 | — | $0 | 4,031,543 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 11,388 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 11,388 | — | $0 | 11,388 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 31,456 | — | $0 | 31,456 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 31,456 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 84,985 | — | $0 | 764,869 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 1,700 | — | $0 | 1,700 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 1,700 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 438,722 | — | $0 | 3,948,495 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2023-11-13 | 2023-11-13 | 849,854 | $5.87 | $4.99M | 849,854 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 888,888 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 900,264 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 526,316 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 1,859,634 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 2,105,264 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 1,153,238 | — | $0 | 3,850,081 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2021-06-15 | 2021-06-16 | 629,411 | $17.00 | $10.70M | 4,479,492 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 2,696,843 | — | $0 | 2,696,843 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 674,211 | — | $0 | 4,387,217 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 2,382,191 | — | $0 | 3,713,006 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 1,138,665 | — | $0 | 1,330,815 | SEC↗ |